Here we observed that inhibition of G9a/GLP suppresses AML-specific blocks of H3K9me2 and leads to a moderate activation of the embedded proto-oncogenes ERG and ETS1 (Fig 7). The gene discussed is ETS1; the disease is acute myeloid leukemia.